Stoke Therapeutics
Sherry L. possesses extensive experience in regulatory affairs within the pharmaceutical industry, currently serving as Executive Director of Regulatory Affairs at Stoke Therapeutics. Prior roles include Senior Director of Regulatory Affairs at Bristol Myers Squibb, as well as Director and Associate Director of Regulatory Affairs at both Celgene and Ono Pharma USA, Inc. Additionally, Sherry has contributed to regulatory functions as an Associate Director at Kyowa Hakko Kirin Pharma, Inc. Sherry holds a Regulatory Affairs Certification (RAC) from the United States.
This person is not in any offices
Stoke Therapeutics
Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.